Juno Therapeutics

Post-lockup, Juno's stock tumbles 5 percent to June low
Bizjournals.com
Sat, 06/27/15 - 11:37 am
Juno Therapeutics
Cancer Therapy Boosts Appeal of Juno, Kite as Targets: Real M&A
Bloomberg
Wed, 06/24/15 - 08:29 am
Juno Therapeutics
Kite Pharma
M&A
cancer
CAR-T
Juno Therapeutics: The Future Of CAR-T Innovation
Seeking Alpha
Sat, 06/20/15 - 09:41 am
Juno Therapeutics
CAR-T
Space in Juno's new Seattle building - get it while it's hot
Bizjournals.com
Wed, 06/17/15 - 06:34 pm
Juno Therapeutics
Seattle
biotech
A cancer cure that excites investors: A look at Seattle's immunotherapy deals of 2015
Bizjournals.com
Wed, 06/10/15 - 09:48 am
cancer immunotherapy
Juno Therapeutics
Top-Performing Biotech and Drug Stocks During ASCO '15
TheStreet.com
Fri, 06/5/15 - 07:13 pm
ASCO
Ignyta
Immunogen
Puma Biotechnology
AbbVie
Roche
Bristol-Myers Squibb
Seattle Genetics
Juno Therapeutics
Want to start a biotech buyout rumor? Start with a company 'like Juno'
Fierce Biotech
Thu, 06/4/15 - 11:56 am
Juno Therapeutics
M&A
Astra Zeneca
Juno stock pops 15 percent after $44M acquisition of Boston-area biotech
Bizjournals.com
Tue, 06/2/15 - 05:11 pm
Juno Therapeutics
X-BODY
M&A
AstraZeneca’s Soriot Open to Buying Immune-Therapy Company
Bloomberg
Tue, 06/2/15 - 04:36 pm
AstraZeneca
Pascal Soriot
M&A
CAR-T
Juno Therapeutics
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
biotech
ASCO
Bristol-Myers Squibb
Immunogen
Oncothyreon
Clovis Oncology
CTI BioPharma
Exelixis
Roche
Amgen
AstraZeneca
Puma Biotechnology
Vascular Biogenics
Immunomedics
Momenta
Eli Lilly
Juno Therapeutics
Express Scripts
Novartis, Juno Killer T-Cells Show Promise In Another Blood Cancer
Forbes
Tue, 06/2/15 - 09:05 am
Novartis
Juno Therapeutics
CAR-T
non-Hodgkin's lymphoma
CAR-T powerhouse Juno allies with gene-editing upstart Editas in $737M deal
Fierce Biotech
Wed, 05/27/15 - 09:57 am
Juno Therapeutics
CAR-T
gene editing
Editas Medicine
ASCO cancer research data drop: What to watch
CNBC
Wed, 05/13/15 - 12:18 pm
ASCO
oncology
cancer
Merck
Bristol-Myers Squibb
AstraZeneca
Juno Therapeutics
CAR-T
Ibrance
Pfizer
elotuzumab
Opdivo
Keytruda
Juno teams with AstraZeneca to explore new therapy, foot the bill for clinical trial
Bizjournals.com
Thu, 04/23/15 - 07:58 pm
Juno Therapeutics
AstraZeneca
cancer immunotherapy
Juno stock drops on report of lackluster immunotherapy results on solid tumors
Bizjournals.com
Mon, 04/20/15 - 05:23 pm
Juno Therapeutics
solid tumors
Novartis
It's A Big Weekend For Biotech
Yahoo/Benzinga
Sat, 04/18/15 - 11:55 am
biotech
Biogen
BIIB037
RG7800
PTC Therapeutics
Alnylam
CAR-T
Merck
Bristol-Myers Squibb
Novartis
Juno Therapeutics
Bellicum
Juno and Novartis settle CAR-T patent fight with little fanfare
Fierce Biotech
Mon, 04/6/15 - 10:07 am
Juno Therapeutics
Novartis
patents
CAR-T
Juno stock drops as company projects up to $150M in cash burn in first post-IPO report
Bizjournals.com
Thu, 03/19/15 - 08:03 am
Juno Therapeutics
Juno since the IPO: Ups and downs, but mostly ups
Bizjournals.com
Tue, 03/17/15 - 08:14 am
Juno Therapeutics
Juno Therapeutics to open Bothell manufacturing facility
Bizjournals.com
Mon, 02/9/15 - 10:04 am
Juno Therapeutics
drug manufacturing

Pages